72
Views
9
CrossRef citations to date
0
Altmetric
Editorial

New medicines for Type 2 diabetes in adolescents: many products, few patients

&
Pages 227-229 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andrew C Rose, William van’t Hoff, Michael W Beresford & Susan P Tansey. (2013) NIHR Medicines for Children Research Network: improving children’s health through clinical research. Expert Review of Clinical Pharmacology 6:5, pages 581-587.
Read now

Articles from other publishers (8)

Klaus Rose. 2021. Considering the Patient in Pediatric Drug Development. Considering the Patient in Pediatric Drug Development 43 262 .
Muhammad Yazid Jalaludin, Margarita Barrientos-Pérez, Mona Hafez, Jane Lynch, Naim Shehadeh, Serap Turan & Daniel Weghuber. (2019) Recommendations for improving clinical trial design to facilitate the study of youth-onset type 2 diabetes. Clinical Trials 17:1, pages 87-98.
Crossref
Ryan Farrell, Kathleen Bethin, Georgeanna Klingensmith, William V. Tamborlane & Rose Gubitosi-Klug. (2017) Barriers to participation in industry-sponsored clinical trials in pediatric type 2 diabetes. Pediatric Diabetes 18:7, pages 574-578.
Crossref
Robin A Huff, Jeff D Maca, Mala Puri & Earl W Seltzer. (2017) Enhancing pediatric clinical trial feasibility through the use of Bayesian statistics. Pediatric Research 82:5, pages 814-821.
Crossref
Kristen J. Nadeau, Barbara J. Anderson, Erika G. Berg, Jane L. Chiang, Hubert Chou, Kenneth C. Copeland, Tamara S. Hannon, Terry T.-K. Huang, Jane L. Lynch, Jeff Powell, Elizabeth Sellers, William V. Tamborlane & Philip Zeitler. (2016) Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities. Diabetes Care 39:9, pages 1635-1642.
Crossref
J. Rick Turner, Kelly L. Close, G. Alexander Fleming, Diane K. Wherrett & Linda A. DiMeglio. (2015) Alternate Approaches for Pediatric Type 1 Diabetes Drug Development and Potential Regulatory Approval: A Perspective. Diabetes Care 38:10, pages 1986-1991.
Crossref
Janina KarresValerie Pratt, Jean-Marc Guettier, Jean Temeck, William V. Tamborlane, David DungerCristina BejnariuCarine De Beaufort & Paolo Tomasi. (2014) Joining Forces: A Call for Greater Collaboration to Study New Medicines in Children and Adolescents With Type 2 Diabetes. Diabetes Care 37:10, pages 2665-2667.
Crossref
Hans-Georg Eichler, Brigitte Bloechl-Daum, Daniel Brasseur, Alasdair Breckenridge, Hubert Leufkens, June Raine, Tomas Salmonson, Christian K. Schneider & Guido Rasi. (2013) The risks of risk aversion in drug regulation. Nature Reviews Drug Discovery 12:12, pages 907-916.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.